<DOC>
	<DOCNO>NCT00994513</DOCNO>
	<brief_summary>The major objective study conduct double-blind , placebo-controlled , randomized clinical trial ass whether oral alpha lipoic acid supplementation decrease cardiovascular disease type 2 diabetes risk obese subject .</brief_summary>
	<brief_title>Effect Alpha Lipoic Acid Obesity Related Comorbidities</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>Han ethnicity BMI≥25kg/m2 Having least one follow risk factor : borderline hypertension ( 130mmHg≤SBP &lt; 140mmHg 85mmHg≤DBP &lt; 90mmHg ) , dyslipidemia ( fast total cholesterol ≥240mg/dl HDLC &lt; 40mg/dl ) , impaired fasting glucose ( fast glucose level 6.1 7.0mmol/L ) 1860 year old Not antioxidant vitamin supplement Pregnancy , lactation childbearing age without birth control device History hypertension , diabetes , coronary heart disease ( CHD ) , cancer liver disease Anything would impede subject comply ALA treatment History psychiatric problem</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Antioxidant</keyword>
	<keyword>Obesity</keyword>
</DOC>